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Accurate chromosome segregation during mitosis
is one of the most fundamental molecular and
cellular processes that allow cells to transmit
faithfully their genetic information from one
generation to another. In eukaryotes, sister chro-
matid cohesion is established during DNA repli-
cation in S phase and maintained during G2 and
early mitosis. At the molecular level, cohesion of
sister chromatids is achieved by cohesin, a multi-
subunit complex.1,2 During prophase, cohesin
along chromosomal arms is removed through
the action of Plk1 (polo-like kinase 1) whereas
the centromeric cohesin is maintained until onset
of anaphase.3,4 Extensive studies have revealed
several independent pathways that regulate the
centromeric cohesion of sister chromatids during
mitosis.
Failure in the maintenance of genetic stability
during cell division leads inevitably to cell death
or malignant transformation. In fact, cancer cells
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Aneuploidy is a major manifestation of chromosomal instability, which is defined as a numerical abnor-
mality of chromosomes in diploid cells. It is highly prevalent in a variety of human malignancies.
Increased chromosomal instability is the major driving force for tumor development and progression. 
To suppress genomic stability during cell division, eukaryotic cells have evolved important molecular
mechanisms, commonly referred to as checkpoints. The spindle checkpoint ensures that cells with defec-
tive mitotic spindles or a defective interaction between the spindles and kinetochores do not initiate chro-
mosomal segregation during mitosis. Extensive studies have identified and characterized more than a
dozen genes that play important roles in the regulation of the spindle checkpoint in mammalian cells.
During the past decade, we have carried out extensive investigation of the role of BubR1 (Bub1-related 
kinase) and Sgo1 (shugoshin 1), two important gene products that safeguard accurate chromosome segre-
gation during mitosis. This mini-review summarizes our studies, as well as those by other researchers 
in the field, on the functions of these two checkpoint proteins and their molecular regulation during 
mitosis. Further elucidation of the molecular mechanisms of the spindle checkpoint regulation has the
potential to identify important mitotic targets for rational anticancer drug design. [J Formos Med Assoc
2009;108(12):904–911]
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frequently exhibit numerical abnormalities in
chromosomes (aneuploidy). Mis-segregation of
chromosomes can result from various causes, in-
cluding spindle checkpoint defects, abnormal cen-
trosome formation, and/or impaired attachment
of spindle microtubules to kinetochores. We have
carried out extensive studies using a combination
of biochemical, molecular and genetic approaches
on several key molecules, including BubR1 and
Sgo1, that control the spindle checkpoint or pro-
tect centromeric cohesion of sister chromatids.
We have demonstrated that spindle checkpoint
impairment caused by defective BubR1 or Sgo1
leads to mis-segregation of sister chromatids and
predisposes mammalian cells to genomic insta-
bility and neoplastic transformation. This mini-
review summarizes our understanding of the role
of BubR1 and Sgo1 in the regulation of the spin-
dle checkpoint and maintenance of chromosomal
stability during mitosis. 
BubR1
In the early 1990s, yeast genetic screening identi-
fied a series of genes that are required for spindle
checkpoint control.5–7 These genes are highly con-
served in higher animals and function as key com-
ponents of the spindle checkpoint. We, and others,
have cloned and characterized human BUB1
(hBUB1) and BUBR1 (hBUBR1 or hMAD3),8–11
which are homologous to yeast BUB1 and
MAD3, respectively. BUB1 and MAD3 orthologs
in mammals share significant sequence homol-
ogy, therefore, MAD3 has been named BUBR1
(Bub1-related).8 Fluorescence microscopy has re-
vealed that BubR1 colocalizes with CREST, a kinet-
ochore antigen, during late G2 and early mitosis
but not after metaphase.9,12 Despite its marked se-
quence homology to yeast MAD3, human BUBR1
possesses a unique C-terminal extension that con-
tains a putative serine–threonine kinase domain;
this protein is phosphorylated extensively during
mitosis, and its phosphorylation correlates with
BUBR1 activation.10 BUBR1 interacts with com-
ponents of APC (anaphase promoting complex),
and this interaction is enhanced in response to
spindle checkpoint activation.9,10,13
The activity and the subcellular localization of
spindle checkpoint proteins including BubR1 are
tightly regulated by phosphorylation during the
cell cycle.10,14 BubR1 functions as a key component
in spindle checkpoint activation, during which it
is extensively phosphorylated.10 BubR1 interacts
directly with Cdc20,15 an activator of the APC/cy-
closome (APC/C), thereby inhibiting the activity
of APC/CCdc20. Hyper-phosphorylated BubR1 and
other components of the checkpoint machinery
including Bub1, Bub3, Mad1, Mad2, and CENP-E
are associated with unattached kinetochores.16,17
Although BubR1 and Mad2 appear to function in
the same signaling pathway after spindle check-
point activation, BubR1 is a much more potent
inhibitor of APC/C than Mad2.18
In addition to the post-translational modifi-
cation by phosphorylation, BubR1 is also sub-
jected to modifications by other mechanisms.
For example, mitotic cells treated with taxol con-
tain not only phosphorylated BubR1, but also a
modified form of BubR1 that migrates much
slower than its phosphorylated counterpart on 
a denaturing SDS polyacrylamide gel (Figure 1,
arrowhead BubR1-M standing for modified






Figure 1. Modifications of BubR1 during mitosis.
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the interphase form after phosphatase treatment.
This is consistent with a recent study that has
shown that BubR1 is acetylated at lysine 250
during prometaphase.18 Acetylated BubR1 is 
required for checkpoint function by inhibition
of the ubiquitin-dependent degradation of this 
protein.18
To study the physiological function of BubR1,
we, and others, have investigated its in vivo func-
tion using a mouse genetic approach.10,19,20 similar
to that of Mad2 null mice, BubR1 null mice are
embryonically lethal.10 BubR1 haploinsufficiency
results in an increase in the number of splenic
megakaryocytes, which is associated with an 
elevated level of megakaryocytic, but not erythro-
cytic, progenitors in bone marrow cells.10 Consis-
tently, BubR1+/− murine embryonic fibroblast cells
also contain a large number of polyploid cells,
frequently accompanied by micronuclei.10 These
observations suggest that deregulated spindle check-
point action caused by inactivation of BubR1 
impairs nuclear division, which results in the
formation of polyploid cells. BubR1 insufficiency
also causes infertility as well as phenotypes char-
acteristic of early aging.21 Specifically, mutant mice
with reduced levels of BubR1 expression develop
symptoms including cachectic dwarfism, cataracts,
lordokyphosis (hunchback spine), loss of subcu-
taneous fat, and reduced wound healing, which
eventually shortens lifespan.21 Development of
these phenotypes in BubR1-deficient mice is asso-
ciated with a compromised spindle checkpoint
because cells from these mice become progres-
sively aneuploid.21 Consistently, mouse embry-
onic fibroblasts (MEFs) with graded reduction in
BubR1 expression also become aneuploid and
senescent,21 which supports the notion that BubR1
may have a function in the control of aging.
Given the major function of BubR1 in regu-
lating chromosomal segregation, it would be an-
ticipated that BubR1 deficiency leads to mitotic
progression with a compromised spindle check-
point. In fact, BubR1-deficient cells are defective in
mitotic arrest in the presence of a microtubule-
depolymerizing agent nocodazole.19,22 Similar to
the role of spindle checkpoint genes in suppression
of tumor development,23,24 BubR1+/− mice are
prone to develop colon and lung adenocarcinomas
upon carcinogen azoxymethane treatment.20
Moreover, in the Apc−/+ genetic background, BubR1
haploinsufficiency causes premature separation
of sister chromatids, genomic instability, and the
development of spontaneous colonic tumors.20
Whereas Apc−/+ mice develop less than one tumor
per mouse (on average), and mice heterozygous
for BubR1 and Apc mutant alleles develop more
than four spontaneous colonic tumors. In addi-
tion, tumors from BubR1+/−Apc−/+ mice are highly
malignant compared with those from Apc−/+ mice.20
These results indicate that haploinsufficiency of
Apc and BubR1 results in a significantly acceler-
ated rate of development, as well as progression,
of colon cancer compared with that of mice with
a single gene deficiency. This suggests that BubR1
and Apc functionally interact in the regulation 
of chromosomal segregation and suppression 
of genomic instability. The importance of BubR1 
in the maintenance of chromosomal stability
and suppression of cancer is supported by a hu-
man study.25 A systematic study of five families
with mosaic variegated aneuploidy, a recessive
condition characterized by mosaic aneuploidy, has
identified mis-sense or truncating mutations in
BubR1. Individuals with mosaic variegated aneu-
ploidy are predisposed to develop childhood can-
cer, including rhabdomyosarcoma, Wilms tumor,
and leukemia.25 This is one of the first studies to
associate germline mutations in a spindle check-
point gene with human cancer, thus strongly
supporting a causal connection between chro-
mosomal mis-segregation, aneuploidy and ma-
lignant transformation.
Environmental toxicants also have a major im-
pact on the integrity of the spindle checkpoint,
by deregulating BubR1. Recently, we have demon-
strated that arsenic trioxide (As2O3) compromises
phosphorylation and activation of BubR1 induced
by paclitaxel.26 Although As2O3 [As(III)] alone
can increase the number of cells in G2/M phase, 
it greatly attenuates paclitaxel-induced mitotic 
arrest. Western blot analysis has shown that As(III)
significantly blocks phosphorylation of BubR1,
Genomic instabilities, BubR1 and Sgo1
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Cdc20 and Cdc27 in cells treated with paclitaxel,
which suggests that arsenic compromises the 
activation of the spindle checkpoint. Our further
analysis has revealed that attenuation of paclitaxel-
induced mitotic arrest by As(III) results primarily
from significantly slowed cell cycle progression
at S phase, but not enhanced mitotic exit.26 Given
that As2O3 also is used widely for the treatment
of several types of malignancy, our studies have
significant clinical implications, because the clin-
ical efficacy of taxol is associated with its ability
to induce mitotic arrest and subsequent mitotic
catastrophe. Precautions need to be taken if
As2O3 and taxol are used in combination for the
treatment of certain cancers.
Sgo1
Sgo1 in budding yeast was originally identified
by several laboratories through independent 
approaches, including searching for genes required
for meiotic progression and for tension-sensitive
mutants that were incapable of attaching sister
chromatids to opposite poles of mitotic spin-
dles.27–29 Sgo1 in budding yeast encodes a protein
of 67 kDa. Mei-S332, an Sgo1 homolog from
Drosophila melanogaster, has been studied exten-
sively long before the Sgo family of proteins
from other species were identified and character-
ized.30–32 Drosophila Mei-S332 gene encodes a
44-kDa protein that is known to maintain sister
chromatid cohesion during meiosis.30,33 Muta-
tional and deletional analyses have revealed cer-
tain functions of specific domains of Mei-S332.
The basic region at the C terminus is required for
its proper subcellular localization, because an
Mei-S332 mutant protein that is missing this re-
gion fails to localize to meiotic and mitotic chro-
mosomes.32,34 The N terminus might also be
involved in regulating the centromeric localiza-
tion of this protein. A mutant Mei-S332 with 
N-terminal truncation produces no discrete lo-
calization patterns; however, Mei-S332 mutants
with a predicted disruption of the coiled coil struc-
ture still maintain their normal localization,32,34
which implies that the N-terminal domain, but
not the coiled coil structure, is necessary for the
guidance of correct subcellular localization of
Mei-S332. Moreover, disruption of the PEST se-
quence does not affect localization of Mei-S332
at centromeres.34
Mammalian Sgo1 was identified through
BLAST search of databases using Sgo1 protein se-
quences of lower eukaryotes.28,35 Reverse tran-
scriptase polymerase chain reaction coupled with
Northern blot analysis has revealed that there are
several alternative splicing variants of SGO1 in
mammalian cells.36 To date, two Sgo1 protein iso-
forms have been characterized extensively, with
molecular weights of about 70 and 42 kDa, re-
spectively.37,38 Structural and functional analyses
have revealed that these two isoforms have two
distinctly different subcellular localizations and
that they function differently in regulating mitotic
progression.37,38 Two putative nuclear localization
signals (amino acids 290–306 and 463–479) are
present in human Sgo1.2 In addition, many con-
sensus sites for phosphorylation by mitotic kinases
(amino acids 192–195, 317–320, and 457–460),
including Aurora kinases and Plks, are found in
human Sgo1.2
Fluorescence microscopy has revealed that
mammalian Sgo1 exhibits distinct subcellular
localization during mitosis in HeLa cells. During
prophase and prometaphase, Sgo1 forms a single
focus between a pair of kinetochores labeled
with CREST.36,39 During metaphase, Sgo1 splits
into two foci that are located between a pair of
CREST signals, but remains situated at the inner
kinetochores that overlap with Aurora B signals.36
Through analysis of green fluorescent protein
(GFP) fusion proteins, we have observed that
Sgo1 primarily localizes to the kinetochores dur-
ing G2 phase and mitotic prophase, metaphase,
and anaphase.37 During late mitosis, Sgo1 does
not appear to be associated with the kinetochores.
Intriguingly, ectopically expressed Sgo1 forms
discrete foci during S phase, some of which are
apparently in the nucleoli; however, a majority
of these foci colocalize with CREST,37 a kineto-
chore antigen, which indicates that Sgo1 is loaded
W. Dai
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onto kinetochores during or immediately after
DNA replication. 
The functional significance of Sgo1 in medi-
ating sister chromatid cohesion was appreciated
initially from genetic studies in yeast.27–29,40,41
Deletion of SGO1 in the budding yeast results in
its sensitivity to the spindle-destabilizing drug
benomyl, and induces premature sister chromatid
separation.27–29 The role of human Sgo1 in regu-
lation of centromeric cohesin has been studied
extensively through the use of RNA interference
(RNAi), as well as expression of dominant nega-
tive mutants. Depletion of human Sgo1 causes
mitotic arrest, coupled with mis-segregation of
sister chromatids.35,36,39,42 In HeLa cells that ec-
topically express myc-tagged Scc1, silencing of
Sgo1 greatly diminishes myc-Scc1 at centromeres
but not along chromosome arms in prometaphase
chromosomes.36,42 These studies suggest that
Sgo1 is required for proper localization of Scc1
at centromeres or protection of cohesin from
centromeric dissociation. We also have observed
that there are two major isoforms of Sgo1 in HeLa
cells.37 Sgo1 (the large form) is kinetochore-
localized, whereas the small form (sSgo1) is con-
centrated at the mitotic spindle and spindle
poles when ectopically expressed.37 Subsequent
studies have revealed that endogenous sSgo1 also
localizes to the centrosome and spindle poles,
and has a role in the maintenance of spindle
pole integrity.38
Mammalian Sgo1 plays a crucial role in medi-
ating proper segregation of sister chromatids at
the onset of anaphase.28,39,42 Cells with depletion
of Sgo1 experience difficulty in chromosome con-
gression; these cells contain clusters of chromo-
somes that surround the spindle poles.28,39,42
Timelapse confocal microscopy has revealed that
most mitotic chromosomes are capable of con-
gression to the metaphase plate, although a sig-
nificant fraction of chromosomes fail to do this,
with lagging chromosomes in Sgo1-depleted cells.
More importantly, at the time when normal cells
initiate anaphase, the metaphase plate appears
to collapse prior to completion of congression of
all chromosome pairs, which results in highly
abnormal chromatid segregation.28 Mis-segrega-
tion of sister chromatids induced by Sgo1 deple-
tion appears to be responsible for dramatic
mitotic arrest.37 We also have obtained evidence
that extended mitotic arrest caused by depletion
of Sgo1 results in apoptosis.43 Taken together,
these studies strongly suggest that mammalian
Sgo1 plays an essential role in the protection of
centromeric cohesin from dissociation before
anaphase onset.
Using biochemical and molecular approaches,
we have demonstrated a new role for Sgo1 in
centriole cohesion.38 Sgo1 depletion via RNAi or
expression of an Sgo1 dominant-negative mu-
tant induces the formation of multiple γ-tubulin
(centrosome) structures in mitotic cells. Subse-
quent studies using cells that constitutively ex-
press GFP–centrin have revealed that multiple
centrosome-like structures result from the sepa-
ration of paired centrioles. A localization study
has indicated that the smaller variant, sSgo1, is
found at the centrosome in interphase and at the
spindle poles in mitosis.38 Centriole splitting in-
duced by Sgo1 depletion or expression of a dom-
inant negative mutant is suppressed by ectopic
expression of sSgo1.38 To confirm a role of Sgo1
in mediating centriole cohesion, we obtained mice
deficient in Sgo1 through a knockout approach.
We have observed that mice homozygous for Sgo1
inactivation are lethal embryonically (unpub-
lished data). We have shown that mitotic Sgo1−/−
MEFs also display an increased number of cen-
trosome-like structures compared with wild-type
MEFs,38 thus confirming the role of Sgo1 in the
maintenance of spindle pole integrity.
Similar to many mitotic proteins, Sgo1 is reg-
ulated by post-translational modifications in-
cluding phosphorylation. A previous study has
shown that Mei-S332 is regulated by phosphory-
lation in Drosophila during the cell cycle.44 Our
Western blot analysis has shown that Sgo1 dur-
ing mitosis undergoes a dramatic shift on dena-
turing gels, and that the shifted Sgo1 collapses to
interphase one after phosphatase treatment,38
which suggests that it is subjected to protein
phosphorylation during mitosis. Consistent with
this, several groups have demonstrated that pro-
tein phosphatase A2 physically interacts with
Sgo1, and is required for normal function of
Sgo1 during mitosis.45–47 Although it remains
unclear what protein kinase(s) is responsible 
for Sgo1 phosphorylation, Plk1 is at least one of
the candidate kinases that are involved in regu-
lating Sgo1 during the cell cycle.48 We have ob-
served that localization of sSgo1 to the spindle
poles is regulated by Plk1, because depletion of
the kinase or mutation of a couple of putative
Plk1-phosphorylation sites compromises the 
accumulation of GFP–sSgo1 at the spindle
poles.38
Our studies have indicated that Sgo1 plays a
dual role in suppressing chromosomal instability
by maintenance of the integrity of sister chroma-
tids and centrioles during mitosis (see the model
in Figure 2). Compromised Sgo1 activity causes
premature separation of sister chromatids and
centrioles (or centrosome splitting), which leads
to chromosomal instability and aneuploidy. In
normal cells, checkpoint mechanisms become in-
volved when there are defects in the mitotic ap-
paratus. Cells with mis-segregated chromosomes
or chromosomal instability are eliminated through
the initiation of mitotic catastrophe (apoptosis).
Many chemical compounds or environmental tox-
icants can compromise control of the spindle
checkpoint because of defective Sgo1. This leads
to chromosomal instability, which can exert strong
pressure for selecting rare aneuploid cells with a
proliferative advantage, which results in oncogenic
transformation and neoplasm. 
Concluding remarks
Underlying chromosomal instability is required
for the generation of multiple lesions that are
characteristic of cancer. Extensive studies using
biochemical, molecular and mouse genetic ap-
proaches have demonstrated a strong link between
deregulation of genes involved in controlling
chromosome segregation during mitosis, and de-
velopment of aneuploidy and cancer. We can ex-
plore the spindle checkpoint defect of malignant
cells by targeting other cell cycle checkpoints,
thereby rendering them more susceptible than
normal cells to therapeutic agents. Mice deficient
in various spindle checkpoint components, such
as BubR1 and Sgo1, are available. They can be ex-
cellent animal models for validating promising
anticancer compounds and screening for new
ones by simultaneously disrupting two or more
cell cycle checkpoint pathways, which leads to
mitotic catastrophe or apoptosis. 
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Figure 2. Dual function of Sgo 1 in maintaining chromosomal
stability during mitosis.
W. Dai
910 J Formos Med Assoc | 2009 • Vol 108 • No 12
References
1. Gruber S, Haering CH, Nasmyth K. Chromosomal cohesin
forms a ring. Cell 2003;112:765–77.
2. Wang X, Dai W. Shugoshin, a guardian for sister chro-
matid segregation. Exp Cell Res 2005;310:1–9.
3. Sumara I, Vorlaufer E, Stukenberg PT, et al. The dissocia-
tion of cohesin from chromosomes in prophase is regu-
lated by Polo-like kinase. Mol Cell 2002;9:515–25.
4. Waizenegger IC, Hauf S, Meinke A, et al. Two distinct
pathways remove mammalian cohesin from chromosome
arms in prophase and from centromeres in anaphase. Cell
2000;103:399–410.
5. Hoyt MA, Totis L, Roberts BT. S. cerevisiae genes required
for cell cycle arrest in response to loss of microtubule
function. Cell 1991;66:507–17.
6. Li R, Murray AW. Feedback control of mitosis in budding
yeast. Cell 1991;66:519–31.
7. Weiss E, Winey M. The Saccharomyces cerevisiae spindle
pole body duplication gene MPS1 is part of a mitotic
checkpoint. J Cell Biol 1996;132:111–23.
8. Cahill DP, Lengauer C, Yu J, et al. Mutations of mitotic check-
point genes in human cancers. Nature 1998;392:300–3.
9. Chan GK, Schaar BT, Yen TJ. Characterization of the kinet-
ochore binding domain of CENP-E reveals interactions
with the kinetochore proteins CENP-F and hBUBR1. J Cell
Biol 1998;143:49–63.
10. Li W, Lan Z, Wu H, et al. BUBR1 phosphorylation is regu-
lated during mitotic checkpoint activation. Cell Growth
Differ 1999;10:769–75.
11. Ouyang B, Lan Z, Meadows J, et al. Human Bub1: a puta-
tive spindle checkpoint kinase closely linked to cell prolif-
eration. Cell Growth Differ 1998;9:877–85.
12. Hoffman DB, Pearson CG, Yen TJ, et al. Microtubule-
dependent changes in assembly of microtubule motor
proteins and mitotic spindle checkpoint proteins at PtK1
kinetochores. Mol Biol Cell 2001;12:1995–2009.
13. Chan GK, Jablonski SA, Sudakin V, et al. Human BUBR1 is
a mitotic checkpoint kinase that monitors CENP-E func-
tions at kinetochores and binds the cyclosome/APC. J Cell
Biol 1999;146:941–54.
14. Chi YH, Haller K, Ward MD, et al. Requirements for protein
phosphorylation and the kinase activity of polo-like kinase 1
(Plk1) for the kinetochore function of mitotic arrest deficiency
protein 1 (Mad1). J Biol Chem 2008;283:35834–44.
15. Wu H, Lan Z, Li W, et al. p55CDC/hCDC20 is associated
with BUBR1 and may be a downstream target of the spin-
dle checkpoint kinase. Oncogene 2000;19:4557–62.
16. Yu H. Regulation of APC-Cdc20 by the spindle check-
point. Curr Opin Cell Biol 2002;14:706–14.
17. Yu H. Cdc20: a WD40 activator for a cell cycle degrada-
tion machine. Mol Cell 2007;27:3–16.
18. Choi E, Choe H, Min J, et al. BubR1 acetylation at
prometaphase is required for modulating APC/C activity
and timing of mitosis. EMBO J 2009;28:2077–89.
19. Dai W, Wang Q, Liu T, et al. Slippage of mitotic arrest and
enhanced tumor development in mice with BubR1 hap-
loinsufficiency. Cancer Res 2004;64:440–5.
20. Rao CV, Yang YM, Swamy MV, et al. Colonic tumorigene-
sis in BubR1+/−Apc−/+ compound mutant mice is linked
to premature separation of sister chromatids and en-
hanced genomic instability. Proc Natl Acad Sci USA
2005;102:4365–70.
21. Baker DJ, Jeganathan KB, Cameron JD, et al. BubR1 insuf-
ficiency causes early onset of aging-associated pheno-
types and infertility in mice. Nat Genet 2004;36:744–9.
22. Wang Q, Liu T, Fang Y, et al. BUBR1 deficiency results in
abnormal megakaryopoiesis. Blood 2004;103;1278–85.
23. Iwanaga Y, Chi YH, Miyazato A, et al. Heterozygous dele-
tion of mitotic arrest-deficient protein 1 (MAD1) increases
the incidence of tumors in mice. Cancer Res 2007;67:
160–6.
24. Michel LS, Liberal V, Chatterjee A, et al. MAD2 haplo-
insufficiency causes premature anaphase and chromo-
some instability in mammalian cells. Nature 2001;409:
355–9.
25. Hanks S, Coleman K, Reid S, et al. Constitutional aneu-
ploidy and cancer predisposition caused by biallelic muta-
tions in BUB1B. Nat Genet 2004;36:1159–61.
26. Duan Q, Komissarova E, Dai W. Arsenic trioxide suppresses
paclitaxel-induced mitotic arrest. Cell Prolif 2009;42:
404–11.
27. Indjeian VB, Stern BM, Murray AW. The centromeric pro-
tein Sgo1 is required to sense lack of tension on mitotic
chromosomes. Science 2005;307:130–3.
28. Kitajima TS, Kawashima SA, Watanabe Y. The conserved
kinetochore protein shugoshin protects centromeric cohe-
sion during meiosis. Nature 2004;427:510–7.
29. Marston AL, Tham WH, Shah H, et al. A genome-wide
screen identifies genes required for centromeric cohesion.
Science 2004;303:1367–70.
30. Davis BK. Genetic analysis of a meiotic mutant resulting 
in precocious sister-centromere separation in Drosophila
melanogaster. Mol Gen Genet 1971;113:251–72.
31. Kerrebrock AW, Moore DP, Wu JS, et al. Mei-S332, a
Drosophila protein required for sister-chromatid cohe-
sion, can localize to meiotic centromere regions. Cell
1995;83:247–56.
32. Tang TT, Bickel SE, Young LM, et al. Maintenance of sister-
chromatid cohesion at the centromere by the Drosophila
MEI-S332 protein. Genes Dev 1998;12:3843–56.
33. Goldstein LS. Mechanisms of chromosome orientation re-
vealed by two meiotic mutants in Drosophila melanogaster.
Chromosoma 1980;78:79–111.
34. Lee JY, Dej KJ, Lopez JM, et al. Control of centromere 
localization of the MEI-S332 cohesion protection protein.
Curr Biol 2004;14:1277–83.
35. Salic A, Waters JC, Mitchison TJ. Vertebrate shugoshin
links sister centromere cohesion and kinetochore micro-
tubule stability in mitosis. Cell 2004;118:567–78.
Genomic instabilities, BubR1 and Sgo1
J Formos Med Assoc | 2009 • Vol 108 • No 12 911
36. McGuinness BE, Hirota T, Kudo NR, et al. Shugoshin 
prevents dissociation of cohesin from centromeres during
mitosis in vertebrate cells. PLoS Biol 2005;3:e86.
37. Wang X, Yang Y, Dai W. Differential subcellular local-
izations of two human Sgo1 isoforms: implications in reg-
ulation of sister chromatid cohesion and microtubule
dynamics. Cell Cycle 2006;5:635–40.
38. Wang X, Yang Y, Duan Q, et al. sSgo1, a major splice vari-
ant of Sgo1, functions in centriole cohesion where it is
regulated by Plk1. Dev Cell 2008;14:331–41.
39. Tang Z, Sun Y, Harley SE, et al. Human Bub1 protects cen-
tromeric sister-chromatid cohesion through Shugoshin
during mitosis. Proc Natl Acad Sci USA 2004;101:
18012–7.
40. Katis VL, Matos J, Mori S, et al. Spo13 facilitates monop-
olin recruitment to kinetochores and regulates maintenance
of centromeric cohesion during yeast meiosis. Curr Biol
2004;14:2183–96.
41. Rabitsch KP, Gregan J, Schleiffer AJ, et al. Two fission
yeast homologs of Drosophila Mei-S332 are required for
chromosome segregation during meiosis I and II. Curr
Biol 2004;14:287–301.
42. Kitajima TS, Hauf S, Ohsugi M, et al. Human Bub1 de-
fines the persistent cohesion site along the mitotic chro-
mosome by affecting Shugoshin localization. Curr Biol
2005;15:353–9.
43. Yang Y, Wang X, Dai W. Human Sgo1 is an excellent target
for induction of apoptosis of transformed cells. Cell Cycle
2006;5:896–901.
44. Clarke AS, Tang TT, Ooi DL, et al. POLO kinase regulates
the Drosophila centromere cohesion protein MEI-S332.
Dev Cell 2005;8:53–64.
45. Kitajima TS, Sakuno T, Ishiguro K, et al. Shugoshin collab-
orates with protein phosphatase 2A to protect cohesin.
Nature 2006;441:46–52.
46. Riedel CG, Katis VL, Katou Y, et al. Protein phosphatase
2A protects centromeric sister chromatid cohesion during
meiosis I. Nature 2006;441:53–61.
47. Tang Z, Shu H, Qi W, et al. PP2A is required for cen-
tromeric localization of Sgo1 and proper chromosome
segregation. Dev Cell 2006;10:575–85.
48. Dai W, Wang X. The Yin and Yang of centromeric cohe-
sion of sister chromatids: mitotic kinases meet protein
phosphatase 2A. Cell Div 2006;1:9.
